Vaistinė Baltbiola - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 385,035 | 413,152 | 391,297 | 389,432 | 349,368 | 310,192 | 294,606 | 310,490 |
| Profit before tax | 12,015 | 23,186 | 29,956 | 9,783 | -17,075 | -14,079 | -11,748 | 1,696 |
| Net profit | 10,140 | 19,516 | 25,336 | 8,177 | -17,075 | -14,079 | -11,748 | 1,602 |
| Equity | 61,793 | 78,999 | 82,335 | 91,229 | 96,154 | 83,233 | 71,485 | 73,087 |
| Liabilities | 65,988 | 66,190 | 79,347 | 54,436 | 27,277 | 42,228 | 21,054 | 42,883 |
| Non-current assets | 137 | 29 | 1,089 | 717 | 963 | 501 | 80 | 224 |
| Current assets | 127,644 | 145,160 | 160,593 | 144,948 | 122,468 | 124,960 | 92,459 | 115,746 |
| Total assets | 127,781 | 145,189 | 161,682 | 145,665 | 123,431 | 125,461 | 92,539 | 115,970 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 47,242 | 44,435 | 38,093 |
| Social insurance contributions | - | - | - | - | - | 18,874 | 18,265 | 17,214 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +11.2% | +7.3% | -5.3% | -0.5% | -10.3% | -11.2% | -5.0% | +5.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.9% | 13.4% | 15.7% | 5.6% | -13.8% | -11.2% | -12.7% | 1.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 16.4% | 24.7% | 30.8% | 9.0% | -17.8% | -16.9% | -16.4% | 2.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.6% | 4.7% | 6.5% | 2.1% | -4.9% | -4.5% | -4.0% | 0.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.1% | 5.6% | 7.7% | 2.5% | -4.9% | -4.5% | -4.0% | 0.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.1 | 0.8 | 1.0 | 0.6 | 0.3 | 0.5 | 0.3 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 48,129 | 51,644 | 48,912 | 50,249 | 49,910 | 44,313 | 47,137 | 52,477 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vaistinė Baltbiola - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-29 | 0.37 |
| 2025-11-18 | 2025-12-03 | 0.37 |
| 2025-04-17 | 2025-04-21 | 24.96 |
| 2025-04-16 | 2025-04-16 | 24.84 |
| 2024-01-16 | 2024-01-16 | 19.25 |
| 2023-04-18 | 2023-04-23 | 196.92 |
| 2022-01-18 | 2022-01-23 | 27.04 |
Vaistinė Baltbiola - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-08 | 2026-03-11 | 212.0 |
| 2025-02-21 | 2025-02-25 | 133.88 |
| 2025-02-20 | 2025-02-20 | 132.96 |
| 2025-01-28 | 2025-01-28 | 34.05 |
| 2025-01-24 | 2025-01-27 | 34.01 |
| 2025-01-15 | 2025-01-23 | 33.92 |
| 2025-01-14 | 2025-01-14 | 33.77 |
| 2024-10-08 | 2024-10-16 | 0.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltbiola, UAB (code 135749619) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €310.5K and recorded net profit of €1.6K, corresponding to a profit margin of 0.5%. This marks a return to profitability after losses of €14.1K in 2023 and €11.7K in 2024, while revenue remained broadly stable over the period. Revenue declined from €310.2K in 2023 to €294.6K in 2024, then recovered in 2025. Over two years, revenue changed by +0.1%, and year-on-year growth in 2025 was +5.4%. At year-end 2025, total assets stood at €116.0K, equity at €73.1K, and liabilities at €42.9K. The equity ratio was 63.0%, with debt to equity at 0.59. Asset turnover reached 2.68x, while return on equity was 2.2% and return on assets 1.4%. Revenue per employee was €62.1K, indicating moderate operating productivity.